Privia Health Group, Inc. (NASDAQ: PRVA) reported Q2 EPS of $0.19, $0.14 better than the analyst estimate of $0.05. Revenue for the quarter came in at $422.3 million versus the consensus estimate of $411.05 million.

Raised Full-Year 2024 Guidance to Mid to High End for All Metrics
Revenue: Mid to High End of $1.6 to 1.675 billion, versus the consensus of $1.667 billion.

For earnings history and earnings-related data on Privia Health Group, Inc. (PRVA) click here.